REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
Is Double Programming Really Required For Validation?
Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
-
Meaningful Industry Change Means Balancing Tech And Human Touch
Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
RWD/RWE RESOURCES
-
Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development
In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.
-
Do CROs Need To Reinvent Themselves In 2025?
Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.
-
Understanding The Perceptions And Potential Of Clinical Research
The PA Consulting Clinical Trials Pulse Report 2024 presents a compelling picture of public perceptions, challenges, and innovation opportunities in clinical trial design and delivery.
-
What's Driving Data Innovation: Notes From The Front Lines Of Change
Clinical data innovators prioritize risk-based quality management, standards, and closer collaboration with research sites. Many see AI as an important support rather than a top priority.
-
Optimize Your Oncology Trial Protocol With Real-World Data
Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on.
-
Choosing An EDC With A Robust API For DTx Clinical Trials
This white paper explores the importance of choosing an EDC with an API before starting a clinical trial.
-
RWD For Early Clinical Development Planning And Strategy
Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.